J.P.M. Burbach

ORCID: 0000-0003-0632-9897
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Colorectal Cancer Surgical Treatments
  • Colorectal and Anal Carcinomas
  • Colorectal Cancer Screening and Detection
  • Health Systems, Economic Evaluations, Quality of Life
  • Radiomics and Machine Learning in Medical Imaging
  • Advanced Radiotherapy Techniques
  • Ethics in Clinical Research
  • Gastric Cancer Management and Outcomes
  • Stoma care and complications
  • Anorectal Disease Treatments and Outcomes
  • Meta-analysis and systematic reviews
  • MRI in cancer diagnosis
  • Radiation Dose and Imaging
  • Palliative Care and End-of-Life Issues
  • Economic and Financial Impacts of Cancer
  • Healthcare cost, quality, practices
  • Patient-Provider Communication in Healthcare
  • Medical Imaging Techniques and Applications
  • Anesthesia and Sedative Agents
  • Childhood Cancer Survivors' Quality of Life
  • Nausea and vomiting management
  • Genetic factors in colorectal cancer
  • Clinical practice guidelines implementation
  • Frailty in Older Adults
  • Diverticular Disease and Complications

University Medical Center Groningen
2018-2022

Medisch Centrum Leeuwarden
2019-2020

University Medical Center Utrecht
2014-2018

Utrecht University
2014-2018

Heidelberg University
2015-2018

University Hospital Heidelberg
2015-2018

Meander Medisch Centrum
2017

Femke J. Amelung Wernard A. A. Borstlap Esther C. J. Consten Joyce Veld Emo E. van Halsema and 95 more Willem A. Bemelman Peter D. Siersema Frank ter Borg Jeanin E. van Hooft Pieter J. Tanis H Algera G. D. Algie C S Andeweg Tanja E. Argillander Melissa N. N. Arron K Arts T H J Aufenacker Ilsalien S. Bakker M Basten Batenburg A.J.N.M. Bastiaansen Geerard L. Beets Andrew Berg B A W van den Beukel R.L.G.M. Blom Björn Blomberg Evert-Jan G. Boerma Frank C. den Boer Nicole D. Bouvy Johanna E. Bouwman N D A Boye Alexandra Brandt Henk Thijs Brandsma A Breijer W.T. van den Broek Mirelle Bröker J.P.M. Burbach Emma R.J. Bruns Thijs A. Burghgraef Rogier M. P. H. Crolla Mikkel Seidelin Dam L. Daniels Jan Willem T. Dekker Ahmet Demirkıran K. W. van Dongen Selim Durmaz Anouk Esch Jeroen A. van Essen J. W. Foppen Edgar J.B. Furnée A. A. W. van Geloven Michael F. Gerhards Erwin A. Gorter Wilhelmina M. U. van Grevenstein Julia T. van Groningen Irene de Groot Hester E. Haak J W A de Haas Pieter van Hagen J. T. Hamminga Klaas Havenga Berber Van Den Hengel E. van der Harst Jeroen Heemskerk Jos Heeren Bob H. M. Heijnen Luc A. Heijnen Joost T. Heikens Maarten van Heinsbergen Daniël A. Hess N Heuchemer Christiaan Hoff Wouter Hogendoorn Alexander P. J. Houdijk Niek Hugen Bas Inberg Ties L. Janssen D Jean Pierre Willem-Jan J. de Jong Audrey C. H. M. Jongen Arnoud V. Kamman Joost M. Klaase Wendy Kelder Emil F Kelling R. Klicks Guus W. de Klein Frank W.H. Kloppenberg Joop Konsten Laura J. E. R. Koolen Verena N. N. Kornmann R.T.J. Kortekaas A Kreiter Bas Lamme Johan F. Lange T. Lettinga Daniel J. Lips Gavin Lo F. Logeman Yu‐Ting van Loon Martijn F. Lutke Holzik C. C. M. Marres

Although self-expandable metal stent (SEMS) placement as bridge to surgery (BTS) in patients with left-sided obstructing colonic cancer has shown promising short-term results, it is used infrequently owing uncertainty about its oncological safety. This population study compared long-term outcomes between emergency resection and SEMS BTS.Through a national collaborative research project, outcome data were collected for all who underwent 2009 2016 75 Dutch hospitals. Patients identified from...

10.1002/bjs.11172 article EN British journal of surgery 2019-05-10

Background: Systematic evaluation and validation of new prognostic predictive markers, technologies interventions for colorectal cancer (CRC) is crucial optimizing patients' outcomes. With only 5–15% patients participating in clinical trials, generalizability results poor. Moreover, current trials often lack the capacity post-hoc subgroup analyses. For this purpose, a large observational cohort study, serving as multiple trial biobanking facility, was set up by Dutch Colorectal Cancer Group...

10.1080/0284186x.2016.1189094 article EN cc-by Acta Oncologica 2016-08-25

IntroductionRectal cancer surgery with neoadjuvant therapy is associated substantial morbidity. The present study describes the course of quality life (QOL) in rectal patients first 2 years after start treatment.Patients and MethodsWe performed a prospective within colorectal cohort including who were referred for chemoradiation or short-course radiotherapy underwent surgery. QOL was assessed using European Organization Research Treatment Cancer core questionnaire (EORTC QLQ-C30) QLQ-CR29)...

10.1016/j.clcc.2018.03.009 article EN cc-by-nc-nd Clinical Colorectal Cancer 2018-03-21

Randomized controlled trials (RCTs)—the gold standard for evaluating the effects of medical interventions—are notoriously challenging in terms logistics, planning and costs. The cohort multiple randomized trial approach is designed to facilitate pragmatic evaluation (new) interventions a promising variation from conventional RCTs. In this paper, we evaluate methodological challenges conducting an RCT within cohort. We argue that equally valid results can be obtained conducted cohorts as...

10.1093/ije/dyw050 article EN International Journal of Epidemiology 2016-04-26

PurposePathologic complete tumor response after chemoradiation in patients with locally advanced rectal cancer (LARC) is associated a favorable prognosis and allows organ-sparing treatment strategies. In the RECTAL-BOOST trial, we aimed to investigate effect of an external radiation boost before on pathologic or sustained clinical LARC.Methods MaterialsThis multicenter, nonblinded, phase 2 randomized controlled trial followed trials-within-cohorts design, which pragmatic design allowing...

10.1016/j.ijrobp.2020.06.013 article EN cc-by International Journal of Radiation Oncology*Biology*Physics 2020-06-18

The "cohort multiple randomized controlled trial," a new design for pragmatic trials, embeds trials within cohort. cohort RCT is an attractive alternative to conventional RCTs in fields where recruitment slow, (competing) interventions the same condition have be tested, are highly preferred by patients and doctors, risk of disappointment bias, cross-over, contamination considerable. To prevent these unwanted effects, provides information on randomization intervention group/arm only, only...

10.1097/ede.0000000000000435 article EN Epidemiology 2016-01-08

Reduction of motion uncertainty by applying adaptive radiotherapy strategies depends largely on the temporal behavior this motion. To fully optimize strategies, insight into target is needed. The purpose study was to analyze stability and evolution in time both gross tumor volume (GTV) clinical (CTV) for patients with rectal cancer. We scanned 16 daily during one week, a 1.5 T MRI scanner treatment position, prior each fraction. Single slice sagittal cine MRIs were made at beginning, middle,...

10.1088/0031-9155/61/1/1 article EN Physics in Medicine and Biology 2015-11-25

ObjectivesThe trials within cohorts (TwiCs) design aims to improve recruitment efficiency. We conducted the first TwiCs in radiation oncology and described efficiency of generalizability results.Study Design SettingIn two radiotherapy centers, patients with rectal cancer were asked participate a prospective cohort study provide broad consent for randomization patient-reported outcomes (PROs). Consenting who met trial criteria randomized directly after enrollment. The intervention arm was...

10.1016/j.jclinepi.2019.12.015 article EN cc-by Journal of Clinical Epidemiology 2019-12-19
Robin Detering Eleonora G. Karthaus Wernard A. A. Borstlap Corrie A.M. Marijnen Cornelis J.�H. van de Velde and 95 more Willem A. Bemelman Geerard L. Beets Pieter J. Tanis Arend G. J. Aalbers Arend G. J. Aalbers Yaïr I. Z. Acherman G. D. Algie B. Alting von Geusau Folker Amelung T.S. Aukema Ilsalien S. Bakker Stephan Bartels Shaik Mahaboob Basha A.J.N.M. Bastiaansen Eric H.J. Belgers Wim Bleeker Joost M. Blok R.J.I. Bosker Joanna W. A. M. Bosmans M. C. Boute Nicole D. Bouvy H. Bouwman Alexandra R. M. Brandt‐Kerkhof David J. Brinkman S. Bruin Emma R.J. Bruns J.P.M. Burbach Jacobus W. A. Burger Christianne J. Buskens S. H. E. M. Clermonts P. P. L. O. Coene C. Compaan E.C.J. Consten T. Darbyshire Sylvana M.L. de Mik Eelco J. R. de Graaf Imelda J. M. de Groot R de Vos tot Nederveen Cappel Johannes H. W. de Wilt James van der Wolde FC den Boer Jan Willem T. Dekker A. Demirkiran M. Derkx-Hendriksen Feike Dijkstra Peter van Duijvendijk M. S. Dunker Q. E. Eijsbouts Hans F. J. Fabry F. Ferenschild J. W. Foppen Edgar J.B. Furnée Michael F. Gerhards P. van Gerven J. A. H. Gooszen Johannes A. Govaert Wilhelmina M. U. van Grevenstein R. Haen Joris J. Harlaar Erwin van der Harst Klaas Havenga Jeroen Heemskerk Jos Heeren B. Heijnen P. Heres Christiaan Hoff Wouter Hogendoorn Piet V. Hoogland A. Huijbers Patricia A. Janssen Audrey C. H. M. Jongen F.H.W. Jonker Eleonora G. Karthaus A. Keijzer J. M. A. Ketel J. Klaase F.W.H. Kloppenberg M.E. Kool R.T.J. Kortekaas P Kruyt Jan-Willem Kuiper Bas Lamme Johan F. Lange T. Lettinga Daniel J. Lips F. Logeman Martijn F. Lutke Holzik Eva V. E. Madsen Aziz Mamound C. C. M. Marres Ilse Masselink M. Meerdink Anand G. Menon J. Sven D. Mieog D. Mierlo

10.1016/j.ejso.2019.06.016 article EN European Journal of Surgical Oncology 2019-06-17

Background: Neoadjuvant chemoradiation with delayed surgery (CRT-DS) and short-course radiotherapy immediate (SCRT-IS) are two commonly used treatment strategies for rectal cancer. However, the optimal strategy patients intermediate-risk cancer remains a discussion. This study compares quality of life (QOL) between SCRT-IS CRT-DS from diagnosis until 24 months after treatment.Methods: In prospective colorectal cohort, clinical stage T2-3N0-2M0 undergoing or 2013 2017 were identified. QOL was...

10.1080/0284186x.2018.1551622 article EN cc-by Acta Oncologica 2019-01-18

Organ-sparing approaches, including wait-and-see and local excision, are increasingly being offered to patients with rectal cancer following a good response neoadjuvant therapy. Preferences regarding these treatment strategies yet unknown.This study aimed determine the preferences utility scores for approaches.This is cross-sectional study.This was conducted at Radiation-Oncology Department of University Medical Center Utrecht.Fifty-seven history 38 volunteers were included.Participants...

10.1097/dcr.0000000000001029 article EN Diseases of the Colon & Rectum 2018-04-25

STopic 1: ContextA1 TwiCs RCTs can be explanatory, pragmatic or in-betweenMerrick Zwarenstein (merrick.zwarenstein@ices.on.ca)Schulich School of Medicine & Dentistry, Western University, London, Ontario, N6A 3K, CanadaRandomised controlled trials (RCTs) using the design streamline patient recruitment by tailoring and staging consent, allow for testing multiple interventions against a common control group, integrate evaluation into natural flow care. Are they pragmatic?Schwartz Lellouch [1]...

10.1186/s13063-017-1961-0 article EN cc-by Trials 2017-06-01

In patients diagnosed with rectal cancer, dose escalation is currently being investigated in a large number of studies. Since there little known on gross tumor volume (GTV) inter-fraction motion for wide variety margins used. Purpose this study to quantify GTV statistics different timescales and give estimates planning target (PTV) margins.Thirty-two patients, were included. To investigate from week-to-week, 16 underwent pretreatment five weekly MRIs, prior radiotherapy (RT) fraction the...

10.1080/0284186x.2018.1532598 article EN cc-by-nc-nd Acta Oncologica 2018-11-16

Abstract Purpose A substantial part (21–35%) of defunctioning stomas created during resection for colorectal cancer will never be reversed. Known risk factors non-closure are age, peri- or postoperative complications, comorbidity, and tumor stage. However, studies performed to identify these mostly focus on rectal include both preoperative factors. This study aims non-reversal intended temporary acute left-sided obstructive colon (LSOCC) with primary anastomosis. Methods All patients who...

10.1007/s00384-020-03559-1 article EN cc-by International Journal of Colorectal Disease 2020-03-24
Sanne-Marije J.A. Hazen Tania C. Sluckin Martijn Intven Geerard L. Beets Regina G. H. Beets‐Tan and 95 more Wernard A. A. Borstlap Tineke E. Buffart Jeroen Buijsen Jacobus W. A. Burger Susan van Dieren Edgar J.B. Furnée Elisabeth D. Geijsen Roel Hompes Karin Horsthuis Jeroen W. A. Leijtens Monique Maas Jarno Melenhorst Joost Nederend Koen Peeters Tom Rozema Jurriaan B. Tuynman Cornelis Verhoef Marianne de Vries Henderik L. van Westreenen Johannes H. W. de Wilt D. D. E. Zimmerman Corrie A.M. Marijnen Pieter J. Tanis Miranda Kusters Arend G. J. Aalbers Susanna M. van Aalten Yaïr I. Z. Acherman Gijs D. Algie E. Boudewijn Alting von Geusau Femke J. Amelung Marjolein Ankersmit Imogeen E. Antonisse J. F. Ashruf Tjeerd S. Aukema Henk Avenarius Renu R. Bahadoer Frans C. H. Bakers Ilsalien S. Bakker Fleur Bangert Renée M. Barendse Stephan Bartels Shaik Mahaboob Basha James van Bastelaar A.J.N.M. Bastiaansen S.C. van Beek Heleen M. D. Beekhuis Eric H J Belgers Willem A. Bemelman Maaike Berbée C. van den Berg H. A. ten Berge Shira H. de Bie Jarmila D. W. van der Bilt Robert H. C. Bisschops Wim Bleeker Joost M. Blok Robin D. Blok Liselotte W. van Bockel Anniek H. Boer Frank C. den Boer Evert-Jan G. Boerma H. Jaap Bonjer Leonora S. F. Boogerd Jaap Borstlap I. van den Bosch Roel Bosker Joanna W. A. M. Bosmans M. C. Boute Nicole D. Bouvy Johanna E. Bouwman Sicco J. Braak Manon N.G.J.A. Braat Jennifer Bradshaw Amarins T. A. Brandsma Alexandra R. M. Brandt‐Kerkhof Vivian van Breest Smallenburg David J. Brinkman W.T. van den Broek S. Bruin Emma R.J. Bruns J.P.M. Burbach Sjirk W. van der Burg Thijs A. Burghgraef Christianne J. Buskens David W.G. ten Cate Heleen M. Ceha S. H. E. M. Clermonts Jeltsje S. Cnossen Robert R.J. Coebergh van den Braak Peter Paul L. O. Coene C. Compaan Esther C. J. Consten Maaike Corver Rogier M. P. H. Crolla Sam Curutchet

Neoadjuvant short-course radiotherapy was routinely applied for nonlocally advanced rectal cancer (cT1-3N0-1M0 with >1 mm distance to the mesorectal fascia) in Netherlands following Dutch total excision trial. This policy has shifted toward selective application after guideline revision 2014.

10.1001/jamaoncol.2023.5444 article EN JAMA Oncology 2023-12-21

To evaluate patients' experience of having served as controls without a notification at the time randomization in context trial within cohorts (TwiCs) design.Patients were asked for their opinion on TwiCs, before and after been provided results. Patients had broad consent to cohort entry one two TwiCs (an exercise program breast cancer treatment or radiotherapy dose-escalation rectal cancer).Two 6 years entry, 15% (n = 16) all patients remembered randomization. Before disclosure results, 47%...

10.1016/j.jclinepi.2022.04.015 article EN cc-by Journal of Clinical Epidemiology 2022-04-15
Coming Soon ...